April 3rd 2025, 9:00pm
By Ryan Scott
Among patients with cancer, high out-of-pocket costs were found to impact access to health care, adherence to medication, as well as quality of life.
April 3rd 2025, 8:00pm
By Sid Salder
Although late-stage kidney cancer generated poor survival rates for over two decades, significant progress is being made in the treatment of the disease.
April 3rd 2025, 7:00pm
By Dr Lillian Siu
April is Head and Neck Cancer Awareness Month, and it is important to be aware of early signs and symptoms of the disease, as well as when to seek care.
April 3rd 2025, 5:00pm
By Natasha Carlson
Lessons I learned from a cancer diagnosis have been applied in some surprising and seemingly unrelated aspects of my life.
April 3rd 2025, 4:01pm
The first patient with locally advanced rectal cancer has been enrolled in the FORTRESS study which is evaluating the investigative immunotherapy NG-350A.
April 3rd 2025, 3:00pm
By Spencer Feldman
Immune response data from FLAMINGO-01 shows positive results in patients with HER2+ breast cancer, suggesting potential for further treatment expansion.
April 3rd 2025, 1:00pm
By Alex Biese
A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on to final analysis.
April 2nd 2025, 9:00pm
The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a form of brain cancer.
April 2nd 2025, 8:00pm
By Dr. Michael J. Pishvaian
There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.
April 2nd 2025, 7:00pm
Adolescent and young adult patients with cancer face delayed diagnoses, financial hardships and gaps in specialized care, creating a need for tailored support.
April 2nd 2025, 5:20pm
By Bonnie Annis
Eleven years post diagnosis and issues related to breast cancer still frustrate me.
April 2nd 2025, 4:35pm
Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a Phase 3 trial.
April 2nd 2025, 3:00pm
A new comprehensive hereditary cancer solution offers genetic counseling and multigene panels to enhance early detection of disease's like brain cancer.
April 2nd 2025, 1:00pm
By Dr. Greg Shaw
Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.
April 1st 2025, 9:00pm
Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.
Bringing Together the CAR T-Cell Therapy Community
Nutrition is Key Following a Cancer Diagnosis
The Leukemia & Lymphoma Society is Helping Patients With Medial Debt
Insights into the Latest Trends in Pancreatic Cancer